NO20055921L - Heterocykliske metylsulfonderivater - Google Patents
Heterocykliske metylsulfonderivaterInfo
- Publication number
- NO20055921L NO20055921L NO20055921A NO20055921A NO20055921L NO 20055921 L NO20055921 L NO 20055921L NO 20055921 A NO20055921 A NO 20055921A NO 20055921 A NO20055921 A NO 20055921A NO 20055921 L NO20055921 L NO 20055921L
- Authority
- NO
- Norway
- Prior art keywords
- substituent
- heterocyclic
- methylsulfone
- derivatives
- heterocyclic group
- Prior art date
Links
- -1 Heterocyclic methylsulfone derivatives Chemical class 0.000 title 1
- 125000001424 substituent group Chemical group 0.000 abstract 5
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 102000013455 Amyloid beta-Peptides Human genes 0.000 abstract 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- RCCPEORTSYDPMB-UHFFFAOYSA-N hydroxy benzenecarboximidothioate Chemical compound OSC(=N)C1=CC=CC=C1 RCCPEORTSYDPMB-UHFFFAOYSA-N 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/14—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003187796 | 2003-06-30 | ||
| JP2004099151 | 2004-03-30 | ||
| PCT/JP2004/009132 WO2005000798A1 (ja) | 2003-06-30 | 2004-06-29 | 複素環メチルスルホン誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20055921L true NO20055921L (no) | 2006-01-24 |
Family
ID=33554493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055921A NO20055921L (no) | 2003-06-30 | 2005-12-13 | Heterocykliske metylsulfonderivater |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7932271B2 (pl) |
| EP (1) | EP1640366A4 (pl) |
| JP (1) | JP4523914B2 (pl) |
| KR (1) | KR20060066057A (pl) |
| AU (1) | AU2004251987C1 (pl) |
| CA (1) | CA2526487A1 (pl) |
| IL (1) | IL172139A0 (pl) |
| MX (1) | MXPA05013631A (pl) |
| NO (1) | NO20055921L (pl) |
| PL (1) | PL379466A1 (pl) |
| RU (1) | RU2336270C2 (pl) |
| TW (1) | TWI328005B (pl) |
| WO (1) | WO2005000798A1 (pl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0108591D0 (en) | 2001-04-05 | 2001-05-23 | Merck Sharp & Dohme | Therapeutic agents |
| GB0120347D0 (en) | 2001-08-21 | 2001-10-17 | Merck Sharp & Dohme | Therapeutic agents |
| AU2002367147A1 (en) * | 2001-12-27 | 2003-07-15 | Daiichi Pharmaceutical Co., Ltd. | Beta-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS |
| GB0223039D0 (en) | 2002-10-04 | 2002-11-13 | Merck Sharp & Dohme | Therapeutic compounds |
| PL379466A1 (pl) | 2003-06-30 | 2006-09-18 | Daiichi Sankyo Company , Limited | Heterocykliczne pochodne metylosulfonu |
| AU2006234441B2 (en) * | 2005-04-08 | 2011-07-07 | Daiichi Sankyo Company, Limited | Pyridylmethylsulfone derivative |
| BRPI0713463A2 (pt) * | 2006-06-22 | 2012-01-24 | Atrazeneca Ab E Astex Therapeutics Ltd | composto, formulação farmacêutica, uso de um composto, e, métodos para inibir a atividade de bace e para tratar ou prevenie uma patologia |
| JP2008115166A (ja) * | 2006-10-10 | 2008-05-22 | Daiichi Sankyo Co Ltd | ピリジルフェニルメチルスルホン誘導体 |
| AU2007324696B2 (en) * | 2006-11-24 | 2012-10-04 | Ac Immune S.A. | N- (methyl) -1H- pyrazol- 3 -amine, N- (methyl) -pyridin-2-amine and N- (methyl) -thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. Alzheimer's |
| TW200920362A (en) | 2007-09-11 | 2009-05-16 | Daiichi Sankyo Co Ltd | Alkylsulfone derivatives |
| AU2008307572A1 (en) | 2007-10-04 | 2009-04-09 | Merck Sharp & Dohme Corp. | Substituted aryl sulfone derivatives as calcium channel blockers |
| EP2311823A1 (en) | 2009-10-15 | 2011-04-20 | AC Immune S.A. | 2,6-Diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases |
| UA103272C2 (uk) * | 2009-12-11 | 2013-09-25 | Ф. Хоффманн-Ля Рош Аг | 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2 |
| US9120752B2 (en) | 2010-07-16 | 2015-09-01 | Purdue Pharma, L.P. | Pyridine compounds as sodium channel blockers |
| US9206127B2 (en) | 2012-03-16 | 2015-12-08 | Purdue Pharm, L.P. | Substituted pyridines as sodium channel blockers |
| WO2014096941A1 (en) | 2012-12-20 | 2014-06-26 | Purdue Pharma L.P. | Cyclic sulfonamides as sodium channel blockers |
| US10730866B2 (en) | 2014-04-07 | 2020-08-04 | Purdue Pharma L.P. | Indole derivatives and use thereof |
| CN109071902B (zh) * | 2016-03-30 | 2021-07-23 | 株式会社尼康 | 可固化组合物、固化制品及光学部件 |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3849423A (en) * | 1971-03-22 | 1974-11-19 | Lilly Co Eli | 3-benzylpyridines |
| US4055652A (en) | 1975-07-07 | 1977-10-25 | Syntex (U.S.A.) Inc. | 1-[β(R-thio)phenethyl]imidazoles and derivatives thereof |
| ZA765075B (en) | 1975-09-25 | 1977-08-31 | American Cyanamid Co | Hypolipemic compounds and method of treatment |
| US4116665A (en) * | 1976-04-02 | 1978-09-26 | Eli Lilly And Company | Method of regulating the growth of aquatic weeds with pyridine derivatives |
| FR2375228A1 (fr) | 1976-12-23 | 1978-07-21 | Parcor | Nouveaux benzothiophenes, leurs procedes de preparation et leur application notamment comme hypolipemiants et hypocholesterolemiants |
| DE2724684A1 (de) | 1977-06-01 | 1978-12-14 | Basf Ag | Triazolsubstituierte schwefelverbindungen |
| DE2735314A1 (de) | 1977-08-05 | 1979-02-22 | Basf Ag | Alpha-azolylsulfide und deren derivate |
| US4675316A (en) | 1978-03-10 | 1987-06-23 | Rohm And Haas Company | Substituted azoylmethylarylsulfides and derivatives and pesticidal use thereof |
| US4257954A (en) * | 1978-08-08 | 1981-03-24 | Sterling Drug Inc. | Novel compounds, processes and marking systems |
| ZA794030B (en) * | 1978-08-08 | 1980-07-30 | Sterling Drug Inc | Aryl sulfinic acid derivatives of aliphatic,aromatic or heterocyclic compounds |
| US4379921A (en) | 1980-08-21 | 1983-04-12 | Sumitomo Chemical Company, Limited | Production of triazolylvinyl ketones |
| FR2509725A1 (fr) | 1981-07-15 | 1983-01-21 | Choay Sa | (hydroxyalkyl)phenylsulfures, leurs procedes de preparation et compositions pharmaceutiques les contenant |
| EP0117485A3 (de) | 1983-02-28 | 1985-01-23 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Pyridin-, Pyrazin- und Pyrimidinderivate und deren Verwendung als fungizide Wirkstoffe |
| DE3406908A1 (de) | 1984-02-25 | 1985-09-05 | Hoechst Ag, 6230 Frankfurt | Neue triazolylalkylderivate, verfahren zu ihrer herstellung sowie ihre verwendung als pflanzenbehandlungsmittel |
| JPS6239563A (ja) | 1985-08-13 | 1987-02-20 | Hokko Chem Ind Co Ltd | β−ニトロフエネチル誘導体および農園芸用殺菌剤 |
| US5359078A (en) | 1989-05-19 | 1994-10-25 | The United States Of America As Represented By The Department Of Health And Human Services | Signal transduction inhibitor compounds |
| DE4215437A1 (de) | 1992-05-11 | 1993-11-18 | Paul Prof Dr Messinger | Darstellung von Alkylacylaten mit ß-ständigen elektronenziehenden Resten im Alkylteil |
| JPH0625168A (ja) | 1992-07-10 | 1994-02-01 | Nippon Bayeragrochem Kk | 殺菌性ベンジルピリジン類 |
| JPH0656780A (ja) * | 1992-08-01 | 1994-03-01 | Nippon Bayeragrochem Kk | 殺菌性α−置換ベンジルピリジン類 |
| DE19521355A1 (de) * | 1995-06-12 | 1996-12-19 | Hoechst Schering Agrevo Gmbh | Sulfonamide, Verfahren zu deren Herstellung und ihre Verwendung als Herbizide und Pflanzenwachstumsregulatoren |
| JPH0995444A (ja) | 1995-10-02 | 1997-04-08 | Teijin Ltd | アミロイド蛋白凝集阻害剤 |
| JP3868354B2 (ja) * | 1997-02-27 | 2007-01-17 | 武田薬品工業株式会社 | アミン誘導体、その製造法および剤 |
| WO1998038156A1 (en) | 1997-02-27 | 1998-09-03 | Takeda Chemical Industries, Ltd. | Amine compounds, their production and use as amyloid-beta production inhibitors |
| GB9902938D0 (en) * | 1999-02-10 | 1999-03-31 | Novartis Ag | Organic compounds |
| MXPA01008606A (es) | 1999-02-26 | 2003-05-05 | Merck & Co Inc | Compuestos de sulfonamida novedosos y uso de los mismos. |
| AU2001240861B2 (en) | 2000-03-20 | 2006-03-30 | Merck Frosst Canada Ltd | Sulphonamido-substituted bridged bicycloalkyl derivatives |
| WO2001094318A2 (en) * | 2000-06-05 | 2001-12-13 | Ortho-Mcneil Pharmaceutical, Inc. | Method for synthesis of substituted azole libraries |
| SG128491A1 (en) * | 2000-12-13 | 2007-01-30 | Wyeth Arqule Inc | Heterocyclic sulfonamide inhibitors of beta amyloid production |
| GB0108591D0 (en) | 2001-04-05 | 2001-05-23 | Merck Sharp & Dohme | Therapeutic agents |
| GB0108592D0 (en) | 2001-04-05 | 2001-05-23 | Merck Sharp & Dohme | Therapeutic agents |
| EP1411944A1 (en) | 2001-08-03 | 2004-04-28 | Schering Corporation | Sulfonamide derivatives as gamma secretase inhibitors |
| TWI242555B (en) | 2001-08-03 | 2005-11-01 | Schering Corp | Novel gamma secretase inhibitors |
| EA006225B1 (ru) | 2001-08-21 | 2005-10-27 | Мерк Шарп Энд Домэ Лимитед | Новые циклогексилсульфоны |
| AU2002357333B2 (en) | 2001-12-20 | 2008-02-28 | Bristol-Myers Squibb Company | Alpha-(N-sulphonamido)acetamide derivatives as Beta-amyloid inhibitors |
| AU2002367147A1 (en) * | 2001-12-27 | 2003-07-15 | Daiichi Pharmaceutical Co., Ltd. | Beta-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS |
| DE10201392A1 (de) | 2002-01-16 | 2003-07-31 | Bayer Ag | Phenylsulfoxide und-sulfone |
| TW200302717A (en) | 2002-02-06 | 2003-08-16 | Schering Corp | Novel gamma secretase inhibitors |
| GB0209997D0 (en) | 2002-05-01 | 2002-06-12 | Merck Sharp & Dohme | Therapeutic agents |
| GB0209991D0 (en) | 2002-05-01 | 2002-06-12 | Merck Sharp & Dohme | Therapeutic agents |
| GB0209995D0 (en) | 2002-05-01 | 2002-06-12 | Merck Sharp & Dohme | Therapeutic agents |
| CA2484159C (en) | 2002-05-01 | 2011-02-22 | Merck Sharp & Dohme Limited | Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase |
| KR20050010882A (ko) | 2002-06-11 | 2005-01-28 | 와이어쓰 | 베타 아밀로이드 생산의 치환 페닐술폰아미드 저해제 |
| WO2004017977A2 (en) | 2002-08-23 | 2004-03-04 | Eli Lilly And Company | 2- (phenoxymethyl)- and 2- (phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors |
| GB0223039D0 (en) | 2002-10-04 | 2002-11-13 | Merck Sharp & Dohme | Therapeutic compounds |
| GB0223038D0 (en) | 2002-10-04 | 2002-11-13 | Merck Sharp & Dohme | Therapeutic compounds |
| GB0223040D0 (en) * | 2002-10-04 | 2002-11-13 | Merck Sharp & Dohme | Therapeutic compounds |
| GB0225475D0 (en) | 2002-11-01 | 2002-12-11 | Merck Sharp & Dohme | Therapeutic agents |
| GB0225474D0 (en) | 2002-11-01 | 2002-12-11 | Merck Sharp & Dohme | Therapeutic agents |
| PL379466A1 (pl) | 2003-06-30 | 2006-09-18 | Daiichi Sankyo Company , Limited | Heterocykliczne pochodne metylosulfonu |
-
2004
- 2004-06-29 PL PL379466A patent/PL379466A1/pl not_active Application Discontinuation
- 2004-06-29 EP EP04746601A patent/EP1640366A4/en not_active Withdrawn
- 2004-06-29 US US10/561,838 patent/US7932271B2/en not_active Expired - Fee Related
- 2004-06-29 AU AU2004251987A patent/AU2004251987C1/en not_active Ceased
- 2004-06-29 CA CA002526487A patent/CA2526487A1/en not_active Abandoned
- 2004-06-29 JP JP2005511074A patent/JP4523914B2/ja not_active Expired - Fee Related
- 2004-06-29 KR KR1020057025070A patent/KR20060066057A/ko not_active Ceased
- 2004-06-29 MX MXPA05013631A patent/MXPA05013631A/es unknown
- 2004-06-29 RU RU2005141552/04A patent/RU2336270C2/ru not_active IP Right Cessation
- 2004-06-29 WO PCT/JP2004/009132 patent/WO2005000798A1/ja not_active Ceased
- 2004-06-30 TW TW093119651A patent/TWI328005B/zh not_active IP Right Cessation
-
2005
- 2005-11-23 IL IL172139A patent/IL172139A0/en unknown
- 2005-12-13 NO NO20055921A patent/NO20055921L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP4523914B2 (ja) | 2010-08-11 |
| RU2336270C2 (ru) | 2008-10-20 |
| US7932271B2 (en) | 2011-04-26 |
| JPWO2005000798A1 (ja) | 2006-08-03 |
| PL379466A1 (pl) | 2006-09-18 |
| HK1090362A1 (zh) | 2006-12-22 |
| AU2004251987C1 (en) | 2010-11-18 |
| RU2005141552A (ru) | 2006-06-27 |
| TW200523251A (en) | 2005-07-16 |
| AU2004251987B2 (en) | 2010-07-01 |
| TWI328005B (en) | 2010-08-01 |
| AU2004251987B8 (en) | 2010-07-22 |
| EP1640366A1 (en) | 2006-03-29 |
| KR20060066057A (ko) | 2006-06-15 |
| EP1640366A4 (en) | 2009-05-13 |
| US20060241302A1 (en) | 2006-10-26 |
| AU2004251987A1 (en) | 2005-01-06 |
| IL172139A0 (en) | 2006-04-10 |
| MXPA05013631A (es) | 2006-02-24 |
| WO2005000798A1 (ja) | 2005-01-06 |
| CA2526487A1 (en) | 2005-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20055921L (no) | Heterocykliske metylsulfonderivater | |
| NO20081464L (no) | 1-heterocyklusulfonyl, 2-aminometyl, 5-(hetero-)aryl subsidiert 1-H-pyrrol-derivater som syresekresjonsinhibitorer | |
| NO20081551L (no) | Heterocyklisk substituerte pyridinderivater og antisoppmidler inneholdende samme | |
| NO20092770L (no) | Nye aminopyrimidinderivater som PLK1-inhibitorer | |
| TW200633991A (en) | Chemical compounds | |
| NO20070457L (no) | Pyrazolderivater | |
| NO20054224L (no) | Nye 2-pyridinkarboksamidderivater | |
| NO20062269L (no) | Pyridin-karboksylsyrederivater som glucokinasemodulatorer | |
| NO20065573L (no) | Orto-substituerte aryl eller heteroarylamidforbindelser | |
| WO2008078196A3 (en) | Substituted heteroaryl pyridopyrimidone derivatives | |
| NO20045369L (no) | Nye, substituerte sulfamatanticonvulsivaderivater | |
| NO20051411L (no) | Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk bruk derav samt intermediater til fremstilling derav | |
| NO20066015L (no) | Fuserte heterosykliske forbindelser | |
| NO20050418L (no) | Kondenserte pyridiner og pyrimidiner med TIE2(TEK) aktivitet | |
| NO20063446L (no) | Tiazolderivater | |
| NO20074763L (no) | (1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi | |
| WO2008136444A1 (ja) | 縮合複素環誘導体 | |
| UA95255C2 (en) | Azole and thiazole derivatives and their use | |
| MY145746A (en) | Heterocyclic substituted pyridine derivatives and antifungal agent containing same | |
| EA200971061A1 (ru) | Пиримидоновые соединения гетероариламидов | |
| WO2009095792A3 (en) | Substituted heteroarylamide diazepinopyrimidone derivatives | |
| NO20082698L (no) | Nye derivater, deres salter og antisoppmidler inneholdende disse | |
| NO20082226L (no) | 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav | |
| NO20074346L (no) | Nye heterocykliske oksimforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20023251L (no) | Nye tetrahydropyridiner, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |